Phase 2b Clinical Trial in Pancreatic Cancer

LAGUNA HILLS, CA, February 28, 2018 (BUSINESS WIRE) — PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today explains PharmaCyte’s plans to conduct a Phase 2b clinical trial. When PharmaCyte met with the FDA in January of 2017, PharmaCyte’s […]

The Iowa Biotechnology Association

The Association has worked steadily to establish a strong identity for the industry and speak with one voice for our diverse membership, seeking to influence policies on both the state and federal level that will enable more efficient growth for Iowa and the United States. Our Association is focused on fostering a stronger business and […]